Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06323954 · ClinicalTrials.gov registry record · NA
tVNS During Motor Training in Older Adults
A NA study of Older Adults, sponsored by Georgia Institute of Technology.
- Recruiting
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT06323954: Recruiting NA study of Older Adults, sponsored by Georgia Institute of Technology.
NCT06323954 is a NA study of Older Adults that is actively recruiting participants, run by Georgia Institute of Technology. The registered enrollment target is 32 participants, below the 224-participant average among 23 other Older Adults trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06323954, a NA study of Older Adults, is actively recruiting participants, sponsored by Georgia Institute of Technology.
- RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to learn about the effect of applying transcutaneous vagus nerve stimulation (tVNS) during motor training on motor learning in older adults. The main question it aims to answer is whether applying tVNS after successful motor trials (post-success tVNS) will facilitate the rate of motor learning. Participants will be randomly assigned to tVNS or sham group and receive tVNS or sham, respectively, at the outer ear during finger control training sessions. Finger control performance will be tested before and after the training sessions without outer ear stimulation.
Primary Outcome
The slope of the reduction in the root mean square error of finger force
Conditions Studied
Interventions
- PROCEDURE tVNS stimulation
- PROCEDURE Sham stimulation
Study Locations (1)
Georgia
- Human Neuromuscular Physiology Lab - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2025-05-27 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What NCT06323954 shows while recruiting
NCT06323954 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 224-participant average among 23 other Older Adults trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Older Adults appearing as the primary indexed condition, and to 2 interventions - of which tVNS stimulation is the first listed.
NCT06323954 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06323954 about?
NCT06323954 is a clinical study titled "tVNS During Motor Training in Older Adults". The goal of this study is to learn about the effect of applying transcutaneous vagus nerve stimulation (tVNS) during motor training on motor learning in older adults. The main question it aims to answer is whether applying tVNS after successful motor trials (post-success tVNS) will facilitate the ra...
What is the current status of trial NCT06323954?
This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2025-05-27. Estimated completion is 2026-07-31.
What conditions does trial NCT06323954 study?
This clinical trial studies the following conditions: Older Adults.
What interventions are being tested in trial NCT06323954?
The interventions under investigation include: tVNS stimulation (PROCEDURE), Sham stimulation (PROCEDURE).
Who is sponsoring clinical trial NCT06323954?
This trial is sponsored by Georgia Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06323954 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Older Adults
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06323954's enrollment target sits among peer trials
32 16th of 23 higher than 7 of 23 other Older Adults trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Older Adults trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Needs Among Older Adults
RECRUITING · NA
-
Influenza Immunization in Adults Over Age 75
RECRUITING · NA
-
A Pilot Randomized Controlled Trial of the Hopeful and Healthy Living Program
RECRUITING · NA
-
Building Resilience for Surgical Recovery
RECRUITING · NA
-
Healthy Aging as Black Adults, In It Together: a Comparative Effectiveness Study of Chronic Pain and Cognitive Decline
RECRUITING · NA
-
Pain and Split-belt Motor Learning in Older Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI